IBTA vs LPTH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IBTA exhibits significant valuation disconnects, trading at a massive premium to its Graham Number ($5.55) and Intrinsic Value ($0.84). While the Piotroski F-Score of 4/9 indicates stable financial health and the balance sheet is clean with very low debt (D/E 0.09), these are overshadowed by deteriorating fundamentals. Revenue growth is negative (-10% YoY) and earnings have collapsed (-87.2% YoY), suggesting the current price is speculative rather than data-driven.
LPTH exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health. While the company shows explosive revenue growth of 120%, it remains deeply unprofitable with a profit margin of -43.45% and a history of missing earnings estimates. The valuation is extreme, with a Price/Sales ratio of 15.75 and a Forward P/E of 110.85, which is not supported by the current earnings trajectory. Aggressive insider selling totaling $35.81M further signals a lack of confidence from company leadership.
Compare Another Pair
Related Comparisons
IBTA vs LPTH: Head-to-Head Comparison
This page compares Ibotta, Inc. (IBTA) and LightPath Technologies, Inc. (LPTH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.